Tactile Medical Launches Next-Generation Flexitouch System: Flexitouch Plus
Flexitouch Plus is the third generation of the Company’s Flexitouch system and features several key enhancements over prior generations. Specifically, the Flexitouch Plus system’s controller has been enhanced with a color display featuring an intuitive user interface and the ability to create and save preset therapy programs. The system’s enhanced controller also enables patients to treat two legs simultaneously, allowing them to complete bilateral therapy in less time. Additionally, the Flexitouch Plus system’s garments have been redesigned to provide improved fit, comfort and coverage and to allow patients to more easily put them on and take them off.
“I am pleased to announce the full commercial launch of our new Flexitouch system, Flexitouch Plus, following the success of our limited market release,” said
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
Legal Notice Regarding Forward-Looking Statements
This release contains forward-looking statements. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “confident,” “outlook” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties outside of the Company’s control that can make such statements untrue, including, but not limited to, the adequacy of the Company’s liquidity to pursue its complete business objectives; the Company’s ability to obtain reimbursement from third party payers for its products; loss or retirement of key executives; adverse economic conditions or intense competition; loss of a key supplier; entry of new competitors and products; adverse federal, state and local government regulation; technological obsolescence of the Company’s products; technical problems with the Company’s research and products; the Company’s ability to expand its business through strategic acquisitions; the Company’s ability to integrate acquisitions and related businesses; price increases for supplies and components; or the inability to carry out research, development and commercialization plans. In addition, other factors that could cause actual results to differ materially are discussed in the Company’s filings with the
Mike Piccinino, CFA Managing Director Westwicke Partners443-213-0500 firstname.lastname@example.org
Source: Tactile Systems Technology, Inc.